Glucotrol XL: Advanced Glycemic Control for Type 2 Diabetes

Glucotrol XL

Glucotrol XL

Price from 37.84 $

Glucotrol XL (glipizide) is an extended-release oral antihyperglycemic agent indicated as an adjunct to diet and exercise for the management of type 2 diabetes mellitus. It belongs to the sulfonylurea class of medications, designed to stimulate insulin secretion from pancreatic beta cells. This formulation provides a controlled release of glipizide, facilitating 24-hour glycemic control with a single daily dose, thereby supporting patient adherence and reducing fluctuations in blood glucose levels. It is a cornerstone therapy for patients where lifestyle modifications alone have proven insufficient.

Features

  • Active ingredient: Glipizide (5 mg or 10 mg)
  • Formulation: Extended-release (ER) gastroretentive tablet
  • Mechanism: Second-generation sulfonylurea; stimulates insulin release from pancreatic beta cells
  • Pharmacokinetics: Once-daily dosing; gradual release over 24 hours
  • Onset of action: Within 2–3 hours; peak effect at 6–12 hours
  • Half-life: 2–4 hours (effective duration prolonged by ER mechanism)
  • Excretion: Primarily hepatic metabolism; metabolites excreted renally

Benefits

  • Provides sustained 24-hour glycemic control with a single daily dose, enhancing patient compliance.
  • Effectively lowers both fasting and postprandial blood glucose levels.
  • Reduces hemoglobin A1c (HbA1c) by an average of 1.5–2.0% in responsive patients.
  • Minimizes peak-trough fluctuations in serum glipizide concentrations, potentially reducing hypoglycemic risk compared to immediate-release formulations.
  • Compatible with other antihyperglycemic agents, allowing for combination therapy when needed.
  • Supports long-term diabetes management with a well-established safety and efficacy profile.

Common use

Glucotrol XL is commonly prescribed for adult patients with type 2 diabetes mellitus whose hyperglycemia cannot be adequately controlled by diet and exercise alone. It is suitable for both newly diagnosed patients and those transitioning from other oral antihyperglycemic agents. The medication is often used as monotherapy but may also be combined with other glucose-lowering drugs, such as metformin or insulin, under careful medical supervision. It is not indicated for type 1 diabetes or diabetic ketoacidosis.

Dosage and direction

The recommended starting dose for Glucotrol XL is 5 mg once daily, taken with breakfast or the first main meal of the day. Dosage may be adjusted in increments of 5 mg at weekly intervals based on blood glucose response, up to a maximum dose of 20 mg per day. Tablets must be swallowed whole and not crushed, chewed, or divided. Consistent timing of administration is important to maintain stable drug levels. Dosage adjustments should be guided by regular monitoring of fasting blood glucose and HbA1c levels.

Precautions

  • Regular self-monitoring of blood glucose is advised to detect hypoglycemia or hyperglycemia.
  • Use with caution in elderly, debilitated, or malnourished patients, and those with adrenal or pituitary insufficiency, due to increased hypoglycemia risk.
  • Hepatic or renal impairment may affect drug metabolism and excretion; dose reduction or alternative therapy may be necessary.
  • Stressful conditions (e.g., fever, trauma, surgery) may necessitate temporary insulin therapy.
  • Alcohol consumption may potentiate hypoglycemic effects and should be avoided or limited.
  • Periodic monitoring of liver function, renal function, and hematologic parameters is recommended during long-term therapy.

Contraindications

  • Hypersensitivity to glipizide, other sulfonylureas, or any component of the formulation.
  • Type 1 diabetes mellitus or diabetic ketoacidosis, with or without coma.
  • Severe renal or hepatic impairment.
  • Concomitant use of bosentan.
  • Pregnancy and breastfeeding; insulin is the preferred therapy during these periods.

Possible side effects

Common side effects may include:

  • Hypoglycemia (sweating, tremor, dizziness, hunger, confusion)
  • Gastrointestinal disturbances (nausea, diarrhea, constipation)
  • Headache
  • Dizziness

Less common but serious side effects:

  • Severe hypoglycemia
  • Hemolytic anemia
  • Allergic skin reactions (rash, urticaria, photosensitivity)
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • Hepatotoxicity
  • Disulfiram-like reaction with alcohol

Drug interaction

Glucotrol XL may interact with:

  • Drugs that increase hypoglycemic risk: insulin, other sulfonylureas, metformin, ACE inhibitors, beta-blockers, fibrates, fluconazole, MAO inhibitors, salicylates, sulfonamides.
  • Drugs that decrease hypoglycemic effect: thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid.
  • Drugs that may prolong or intensify hypoglycemia: beta-blockers, clonidine, reserpine, guanethidine, alcohol.
  • Drugs affected by protein-binding displacement: warfarin, NSAIDs, salicylates.

Missed dose

If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one. Consistent daily timing is important to maintain glycemic control.

Overdose

Symptoms of overdose primarily include severe hypoglycemia (sweating, tremor, seizures, coma). Management consists of immediate glucose administration (oral or intravenous, depending on consciousness). Close monitoring for at least 24–48 hours is necessary due to the prolonged drug effect. In cases of intentional overdose, gastric lavage and activated charcoal may be considered if presented early.

Storage

Store at controlled room temperature (20–25°C or 68–77°F). Protect from moisture and light. Keep in the original container, tightly closed. Do not use if tablets are discolored, broken, or show signs of deterioration. Keep out of reach of children and pets.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Glucotrol XL is a prescription medication and should be used only under the supervision of a qualified healthcare provider. Dosage, indications, and precautions may vary based on individual patient factors. Always consult a healthcare professional for personalized medical advice.

Reviews

Clinical studies and post-marketing surveillance indicate that Glucotrol XL is effective in achieving glycemic control in a majority of patients with type 2 diabetes. Patients report improved convenience due to once-daily dosing and reduced glycemic variability. Some users note gastrointestinal discomfort initially, which often subsides with continued use. Healthcare providers emphasize the importance of adherence to dietary and lifestyle recommendations alongside pharmacotherapy for optimal outcomes.